CDC5L and Miyoshi myopathy: For the first time, we showed that BTYNB suppressed CDC5L expression in MM cells with 1q+ and effectively inhibited their proliferation both in vitro and in vivo, which implies the candidacy of BTYNB for further therapeutic development.